145 related articles for article (PubMed ID: 10698035)
1. Relationship between ovarian stimulation regimen and cytokine concentration in follicular fluid and their effect on fertilization and pregnancy outcome of patients undergoing ICSI program.
Hammadeh ME; Braemert B; Baltes S; Georg T; Rosenbaum P; Schmidt W
Am J Reprod Immunol; 2000 Jan; 43(1):12-20. PubMed ID: 10698035
[TBL] [Abstract][Full Text] [Related]
2. Relationship between ovarian stimulation regimen and interleukin level in pre-ovulatory follicular fluid and their effect on ICSI outcome.
Hammadeh ME; Ertan AK; Georg MT; Rosenbaum P; Schmidt W
Am J Reprod Immunol; 2002 Oct; 48(4):255-61. PubMed ID: 12516637
[TBL] [Abstract][Full Text] [Related]
3. Comparison between cytokine concentration in follicular fluid of poor and high responder patients and their influence of ICSI-outcome.
Hammadeh ME; Fischer-Hammadeh C; Georg T; Rosenbaum P; Schmidt W
Am J Reprod Immunol; 2003 Aug; 50(2):131-6. PubMed ID: 12846676
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor (FGF), intracellular adhesion molecule (sICAM-1) level in serum and follicular fluid of infertile women with polycystic ovarian syndrome, endometriosis and tubal damage, and their effect on ICSI outcome.
Hammadeh ME; Fischer-Hammadeh C; Hoffmeister H; Huebner U; Georg T; Rosenbaum P; Schmidt W
Am J Reprod Immunol; 2003 Aug; 50(2):124-30. PubMed ID: 12846675
[TBL] [Abstract][Full Text] [Related]
5. IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol.
Asimakopoulos B; Schöpper B; Dawson A; Caglar GS; Vakalopoulos I; Al-Hasani S; Diedrich K; Nikolettos N
J Endocrinol Invest; 2006 May; 29(5):RC5-8. PubMed ID: 16794358
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist.
Bahceci M; Ulug U; Turan E; Akman MA
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):93-8. PubMed ID: 16720073
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles.
Ferrari B; Pezzuto A; Barusi L; Coppola F
Gynecol Endocrinol; 2006 Jun; 22(6):289-96. PubMed ID: 16785153
[TBL] [Abstract][Full Text] [Related]
8. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
9. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
10. Relationship between cytokine concentrations (FGF, sICAM-1 and SCF) in serum, follicular fluid and ICSI outcome.
Hammadeh ME; Fischer-Hammadeh C; Hoffmeister H; Herrmann W; Rosenbaum P; Schmidt W
Am J Reprod Immunol; 2004 Jan; 51(1):81-5. PubMed ID: 14725569
[TBL] [Abstract][Full Text] [Related]
11. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
[TBL] [Abstract][Full Text] [Related]
12. Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.
Liu N; Ma Y; Li R; Jin H; Li M; Huang X; Feng HL; Qiao J
Endocrine; 2012 Dec; 42(3):708-16. PubMed ID: 22678853
[TBL] [Abstract][Full Text] [Related]
13. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropins induce the release of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha from the human preovulatory follicle.
Loret de Mola JR; Goldfarb JM; Hecht BR; Baumgardner GP; Babbo CJ; Friedlander MA
Am J Reprod Immunol; 1998 Jun; 39(6):387-90. PubMed ID: 9645270
[TBL] [Abstract][Full Text] [Related]
15. Assessment of follicular and serum VEGF and IGF-1 in ICSI patients: hMG vs rFSH.
Bilge M; Ozdemirci S; Esinler D; Karahanoglu E; Esinler I; Aksu T
Clin Exp Obstet Gynecol; 2015; 42(5):576-9. PubMed ID: 26524801
[TBL] [Abstract][Full Text] [Related]
16. Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH.
Balasch J; Vidal E; Peñarrubia J; Casamitjana R; Carmona F; Creus M; Fábregues F; Vanrell JA
Hum Reprod; 2001 Aug; 16(8):1636-43. PubMed ID: 11473955
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive pills and follicular fluid hormones in an in vitro fertilization program.
Weisman Z; Dirnfeld M; Lissak A; Sorokin Y; Abramovici H
Fertil Steril; 1989 Sep; 52(3):451-3. PubMed ID: 2506078
[TBL] [Abstract][Full Text] [Related]
19. Relationship between sex hormone-binding globulin and pregnancy outcome in women undergoing controlled ovarian hyperstimulation for assisted reproduction.
Lin KC; Sun MJ
Endocr J; 2005 Aug; 52(4):407-12. PubMed ID: 16127207
[TBL] [Abstract][Full Text] [Related]
20. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
